Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma

Neil L. Berinstein, A.J. Grillo-López, Christine A. White et al. · Annals of Oncology · 1998 · 523 citations · Full text

Medicine, Hematology, Oncology +15

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

Kazuyoshi Saito, Daisuke Kawabata, Shingo Nakayamada et al. · Annals of the Rheumatic Diseases · 2006 · 345 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics1

Carlos Alexandre Vieira, Avinash Kumar Ágarwal, Benita K. Book et al. · Transplantation · 2004 · 271 citations

Medicine, Immunology, Pharmacology +15

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

Vincent Guigonis, A. Dallocchio, Véronique Baudouin et al. · Pediatric Nephrology · 2008 · 249 citations

Medicine, Nephrology, Pharmacotherapy +8

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

Kerstin Benz, J�rg D�tsch, Wolfgang Rascher et al. · Pediatric Nephrology · 2004 · 206 citations

Medicine, Nephrology, Pharmacotherapy +11